trending Market Intelligence /marketintelligence/en/news-insights/trending/KNVPRHCiRi0vTUybFFxgsQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Novelion Therapeutics completes reverse stock split

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Novelion Therapeutics completes reverse stock split

Novelion Therapeutics Inc. completed a planned 1-to-5 reverse stock split.

The company will now have 18,530,700 shares issued and outstanding with trading to resume on Nasdaq on Dec. 19 and the Toronto Stock Exchange on Dec. 21.